TAS-106

DRUG2 trials

Sponsors

Taiho Pharmaceutical Co., Ltd., M.D. Anderson Cancer Center

Conditions

CancerHead and Neck CancerSolid Tumors

Phase 1

Phase I Study of TAS-106 in Combo With Carboplatin

CompletedNCT00752011

M.D. Anderson Cancer CenterCancer, Solid Tumors

Start: 2008-06-30Updated: 2012-10-18

Phase 2

Phase II Study of TAS-106 to Treat Head and Neck Cancer

TerminatedNCT00737360

Taiho Pharmaceutical Co., Ltd.Head and Neck Cancer

Start: 2008-08-31End: 2012-02-29Updated: 2012-09-05